The figures highlight double-digit revenue growth, margin expansion, and continued momentum in complex generics and peptides CDMO platform
The results signal shift beyond paclitaxel-coated balloon (PCB) angioplasty in femoropopliteal artery disease
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
_256_384.png)
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
Subscribe To Our Newsletter & Stay Updated
